Skip to main content
SpringerLink
Log in

Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors

  • Review Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Adverse drug reactions (ADRs) are one of the leading causes of hospital admissions and morbidity in developed countries and represent a substantial burden on healthcare delivery systems. However, there is little data available from low- and middle-income countries. This review compares the prevalence and characteristics of ADR-related hospitalisations in adults in developed and developing countries, including the mortality, severity and preventability associated with these events, commonly implicated drugs and contributing factors. A literature search was conducted via PubMed, Scopus, Web of Science, Embase, ProQuest and Google Scholar to find articles published in English from 2000 to 2015. Relevant observational studies were included. The median (with interquartile range [IQR]) prevalence of ADR-related hospitalisation in developed and developing countries was 6.3 % (3.3–11.0) and 5.5 % (1.1–16.9), respectively. The median proportions of preventable ADRs in developed and developing countries were 71.7 % (62.3–80.0) and 59.6 % (51.5–79.6), respectively. Similarly, the median proportions of ADRs resulting in mortality in developed and developing countries were 1.7 % (0.7–4.8) and 1.8 % (0.8–8.0), respectively. Commonly implicated drugs in both settings were antithrombotic, non-steroidal anti-inflammatory and cardiovascular drugs. Older age, female gender, number of medications, renal impairment and heart failure were reported to be associated with an increased risk for ADR-related hospitalisation in both settings while HIV/AIDS was implicated in developing countries only. The majority of ADRs were preventable in both settings, highlighting the importance of improving medication use, particularly in vulnerable patient groups such as the elderly, patients with multiple comorbidities and, in developing countries, patients with HIV/AIDS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. World Health Organisation (WHO). Safety of medicine: a guide to detecting and reporting adverse drug reaction. Geneva: WHO; 2002.

    Google Scholar 

  2. Wester K, Jonsson AK, Spigset O, Druid H, Hagg S. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol. 2008;65:573–9.

    Article  PubMed  Google Scholar 

  3. Sonal Sekhar M, Adheena Mary C, Anju PG, Hamsa NA. Study on drug related hospital admissions in a tertiary care hospital in South India. Saudi Pharm J SPJ Off Publ Saudi Pharm Soc. 2011;19:273–8.

    CAS  Google Scholar 

  4. Varallo FR, Lima MFR, Galduroz JCF, Mastroianni PC. Adverse drug reaction as cause of hospital admission of elderly people: a pilot study. Latin Am J Pharm. 2011;30:347–53.

    Google Scholar 

  5. Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden R, Barnes KI. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol. 2008;65:396–406.

    Article  PubMed  Google Scholar 

  6. Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R, Gambassi G. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50:1962–8.

    Article  PubMed  Google Scholar 

  7. Sánchez Muñoz-Torrero JF, Barquilla P, Velasco R, Fernández Capitan MDC, Pacheco N, Vicente L, Chicón JL, Trejo S, Zamorano J, Lorenzo Hernandez A. Adverse drug reactions in internal medicine units and associated risk factors. Eur J Clin Pharmacol. 2010;66:1257–64.

    Article  PubMed  Google Scholar 

  8. Zopf Y, Rabe C, Neubert A, Hahn EG, Dormann H. Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf. 2008;31:789–98.

    Article  PubMed  Google Scholar 

  9. Perez Menendez-Conde C, Bermejo Vicedo T, Delgado Silveira E, Carretero Accame E. Adverse drug reactions which provoke hospital admission. Farmacia Hospitalaria Organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 2011;35:236–43.

    CAS  PubMed  Google Scholar 

  10. Alomar MJ. Factors affecting the development of adverse drug reactions (review article). Saudi Pharm J SPJ Off Publ Saudi Pharm Soc. 2014;22:83–94.

    Google Scholar 

  11. McDowell SE, Coleman JJ, Ferner R. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ. 2006;332:1177–81.

    Article  CAS  PubMed  Google Scholar 

  12. Hofer-Dueckelmann C, Prinz E, Beindl W, Szymanski J, Fellhofer G, Pichler M, Schuler J. Adverse drug reactions (ADRs) associated with hospital admissions—elderly female patients are at highest risk. Int J Clin Pharmacol Ther. 2011;49:577–86.

    Article  CAS  PubMed  Google Scholar 

  13. Mannesse CK, Derkx FHM, de Ridder MAJ, t Veld A, van der Cammen TJM. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing. 2000;29:35–9.

    Article  CAS  PubMed  Google Scholar 

  14. European Commission. Pharmacovigilance Impact Assessment. 2008. http://ec.europa.eu/health/files/pharmacos/pharmpack_12_2008/pharmacovigilance-ia-vol1_en.pdf. Accessed on 10 June 2016.

  15. Alhawassi TM, Krass I, Bajorek BV, Pont LG. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging. 2014;9:2079–86.

    PubMed  PubMed Central  Google Scholar 

  16. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255–9.

    Article  CAS  PubMed  Google Scholar 

  17. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.

    Article  CAS  PubMed  Google Scholar 

  18. World Health Organisation (WHO). The use of the WHO-UMC system for standardised case causality assessment via http://who-umc.org/Graphics/24734.pdf.

  19. Al Hamid A, Ghaleb M, Aljadhey H, Aslanpour Z. A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol. 2014;78:202–17.

    Article  PubMed  Google Scholar 

  20. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): A meta-analysis of observational studies. Pharm World Sci. 2002;24:46–54.

    Article  CAS  PubMed  Google Scholar 

  21. Howard R, Avery A, Slavenburg S, Royal S, Pipe G, Lucassen P, Pirmohamed M. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63:136–47.

    Article  CAS  PubMed  Google Scholar 

  22. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42:1017–25.

    Article  PubMed  Google Scholar 

  23. Lazarou J, Pomeranz B, Corey P. Incidence of adverse drug reactions in hospitalised patients. a meta-analysis of prospective studies. J Am Med Assoc. 1998;279:1200–5.

    Article  CAS  Google Scholar 

  24. Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studies. Bandolier Extra. 2002;101:1–15.

    Google Scholar 

  25. Dimie O, Reginald OO, Haruna MM, Mukhtar A, Aliyu B, Abdulaziz H, Isa B, Henry I, Matthew I, Eric TA. Morbidity and mortality patterns of hospitalised adult HIV/AIDS patients in the era of highly active antiretroviral therapy: a 4-year retrospective review from Zaria. Northern Nigeria. AIDS Res Treat. 2012;2012:1–11.

    Google Scholar 

  26. Henry NL, Marie-Solange D, Simeon-Pierre C, Elvis T, Gloria A, Henry A, Sinata K-S. Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study. Pan Afr Med J. 2012;12:1–7.

    Google Scholar 

  27. Van Olmen J, Schellevis F, Van Damme W, Kegels G, Rasschaert F. Management of chronic diseases in Sub-Saharan Africa: cross-fertilisation between HIV/AIDS and diabetes care. J Trop Med. 2012;2012:349312.

    PubMed  PubMed Central  Google Scholar 

  28. CIA.Country comparison: life expectancy at birth. 2015. https://www.cia.gov/library/publications/the-world-factbook/rankorder/2102rank.html. Accessed on 9 June 2016 at 5:50PM.

  29. World Health Organisation (WHO). Counterfeit medicines: an update on estimates. 2006. http://www.who.int/medicines/services/counterfeit/impact/TheNewEstimatesCounterfeit.pdf. Accessed on June 2016.

  30. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229–32.

    CAS  PubMed  Google Scholar 

  31. Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care. 2004;13:306–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, Haghfelt T, Damsbo N. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228:83–90.

    Article  CAS  PubMed  Google Scholar 

  33. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27:538.

    CAS  PubMed  Google Scholar 

  34. Rawlins MD, Thompson JW. Pathogenesis of adverse drug reactions. In: Davies DM, editor. Textbook of adverse drug reactions. Oxford: Oxford University Press; 1981. p. 11.

    Google Scholar 

  35. World Bank. Comparing levels of development. 1995. http://www.worldbank.org/depweb/beyond/beyondco/beg_02.pdf. Accessed on Dec 22 2015 at 3:00PM.

  36. Van der Hooft CS, Sturkenboom MC, Van Grootheest K, Kingma HJ, Stricker BH. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. Drug Saf. 2006;29:161–8.

    Article  PubMed  Google Scholar 

  37. Pedros C, Quintana B, Rebolledo M, Porta N, Vallano A, Arnau JM. Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission. Eur J Clin Pharmacol. 2014;70:361–7.

    Article  CAS  PubMed  Google Scholar 

  38. Rottenkolber D, Schmiedl S, Rottenkolber M, Farker K, Salje K, Mueller S, Hippius M, Thuermann PA, Hasford J. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf. 2011;20:626–34.

    Article  PubMed  Google Scholar 

  39. Ahern F, Sahm LJ, Lynch D, McCarthy S. Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: a cross-sectional study. Emerg Med J EMJ. 2014;31:24–9.

    Article  PubMed  Google Scholar 

  40. Alvarez PA, Bril F, Castro V, Meiville I, Gonzalez CD, Centurion IG, Parejas G, Riera CS, Saubidet CL, Di Girolamo G, Keller GA. Adverse drug reactions as a reason for admission to an internal medicine ward in Argentina. Int J Risk Saf Med. 2013;25:185–92.

    PubMed  Google Scholar 

  41. Franceschi M, Scarcelli C, Niro V, Seripa D, Pazienza AM, Pepe G, Colusso AM, Pacilli L, Pilotto A. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a Geriatric Unit—a prospective study of 1756 patients. Drug Saf. 2008;31:545–56.

    Article  PubMed  Google Scholar 

  42. Mjorndal T, Boman MD, Hagg S, Backstrom M, Wiholm BE, Wahlin A, Dahlqvist R. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf. 2002;11:65–72.

    Article  PubMed  Google Scholar 

  43. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ. 2004;329:15–9.

    Article  PubMed  PubMed Central  Google Scholar 

  44. von Euler M, Eliasson E, Ohlen G, Bergman U. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf. 2006;15:179–84.

    Article  Google Scholar 

  45. Alexopoulou A, Dourakis SP, Mantzoukis D, Pitsariotis T, Kandyli A, Deutsch M, Archimandritis AJ. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Intern Med. 2008;19:505–10.

    Article  PubMed  Google Scholar 

  46. Hopf Y, Watson M, Williams D. Adverse-drug-reaction related admissions to a hospital in Scotland. Pharm World Sci. 2008;30:854862.

    Article  Google Scholar 

  47. Olivier P, Bertrand L, Tubery M, Lauque D, Montastruc JL, Lapeyre-Mestre M. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging. 2009;26:475–82.

    Article  PubMed  Google Scholar 

  48. Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA, Gogtay NJ. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol. 2007;7:8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Ruiter R, Visser LE, Rodenburg EM, Trifiro G, Ziere G, Stricker BH. Adverse drug reaction-related hospitalizations in persons aged 55 years and over: a population-based study in the Netherlands. Drugs Aging. 2012;29:225–32.

    Article  PubMed  Google Scholar 

  50. Brvar M, Fokter N, Bunc M, Mozina M. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC Clin Pharmacol. 2009;9:8.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Pouyanne P, Haramburu F, Imbs JL, Begaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ. 2000;320:1036.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. van der Hooft CS, Dieleman JP, Siemes C, Aarnoudse AJL, Verhamme K, Stricker BH, Sturkenboom MC. Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf. 2008;17:365–71.

    Article  PubMed  Google Scholar 

  53. Carrasco-Garrido P, de Andres LA, Barrera VH, de Miguel GA, Jimenez-Garcia R. Trends of adverse drug reactions related-hospitalizations in Spain (2001–2006). BMC Health Serv Res. 2010;10:287.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Tumwikirize WA, Ogwal-Okeng JW, Vernby A, Anokbonggo WW, Gustafsson LL, Lundborg SC. Adverse drug reactions in patients admitted on internal medicine wards in a district and regional hospital in Uganda. Afr Health Sci. 2011;11:72–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Noblat AC, Noblat LA, Toledo LA, Santos Pde M, Oliveira MG, Tanajura GM, Spinola SU, Almeida JR. Prevalence of hospital admission due to adverse drug reaction in Salvador, Bahia. Revista Da Associacao Medica Brasileira (1992). 2011;57:42–5.

    Google Scholar 

  56. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital—their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003;12:687–92.

    Article  CAS  PubMed  Google Scholar 

  57. Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol. 2002;58:285–91.

    Article  PubMed  Google Scholar 

  58. Chen YC, Fan JS, Chen MH, Hsu TF, Huang HH, Cheng KW, Yen DH, Huang CI, Chen LK, Yang CC. Risk factors associated with adverse drug events among older adults in emergency department. Eur J Intern Med. 2014;25:49–55.

    Article  PubMed  Google Scholar 

  59. Green CF, Mottram DR, Rowe PH, Pirmohamed M. Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. J Clin Pharm Ther. 2000;25:355–61.

    Article  CAS  PubMed  Google Scholar 

  60. Patel H, Bell D, Molokhia M, Srishanmuganathan J, Patel M, Car J, Majeed A. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005. BMC Clin Pharmacol. 2007;7:9.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Zopf Y, Rabe C, Neubert A, Gassmann KG, Rascher W, Hahn EG, Brune K, Dormann H. Women encounter ADRs more often than do men. Eur J Clin Pharmacol. 2008;64:999–1004.

    Article  CAS  PubMed  Google Scholar 

  62. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365:2002–12.

    Article  CAS  PubMed  Google Scholar 

  63. Chen YC, Fan JS, Hsu TF, Chen MH, Huang HH, Cheng KW, Yen DH, Huang MS, Lee CH, Chen LK, Yang CC. Detection of patients presenting with adverse drug events in the emergency department. Intern Med J. 2012;42:651–7.

    Article  PubMed  Google Scholar 

  64. Hartholt KA, van der Velde N, Looman CW, Panneman MJ, van Beeck EF, Patka P, van der Cammen TJ. Adverse drug reactions related hospital admissions in persons aged 60 years and over, The Netherlands, 1981–2007: less rapid increase, different drugs. PLoS One. 2010;5:e13977.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Begaud B. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol. 2000;56:181–6.

    Article  CAS  PubMed  Google Scholar 

  66. Matanovic SM, Vlahovic-Palcevski V. Potentially inappropriate prescribing to the elderly: comparison of new protocol to Beers criteria with relation to hospitalizations for ADRs. Eur J Clin Pharmacol. 2014;70:483–90.

    Article  PubMed  Google Scholar 

  67. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36:1331–6.

    Article  PubMed  Google Scholar 

  68. Pourseyed S, Fattahi F, Pourpak Z, Gholami K, Shariatpanahi SS, Moin A, Kazemnejad A, Moin M. Adverse drug reactions in patients in an Iranian department of internal medicine. Pharmacoepidemiol Drug Saf. 2009;18:104–10.

    Article  PubMed  Google Scholar 

  69. Tipping B, Kalula S, Badri M. The burden and risk factors for adverse drug events in older patients—a prospective cross-sectional study. South Afr Med J Suid Afrikaanse Tydskrif Vir Geneeskunde. 2006;96:1255–9.

    Google Scholar 

  70. Varallo FR, Capucho HC, Planeta CD, Mastroianni PD. Possible adverse drug events leading to hospital admission in a Brazilian teaching hospital. Clinics. 2014;69:163–7.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Walsh D, Lavan A, Cushen AM, Williams D. Adverse drug reactions as a cause of admission to a Dublin-based university teaching hospital. Ir J Med Sci. 2015;184:441–7.

    Article  CAS  PubMed  Google Scholar 

  72. Kongkaew C, Hann M, Mandal J, Williams SD, Metcalfe D, Noyce PR, Ashcroft DM. Risk factors for hospital admissions associated with adverse drug events. Pharmacotherapy. 2013;33:827–37.

    Article  PubMed  Google Scholar 

  73. Zhong W, Maradit-Kremers H, St Sauver JL, Yawn BP, Ebbert JO, Roger VL, Jacobson DJ, McGree ME, Brue SM, Rocca WA. Age and sex patterns of drug prescribing in a defined American population. Mayo Clin Proc. 2013;88:697–707.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Rodenburg EM, Stricker BH, Visser LE. Sex differences in cardiovascular drug-induced adverse reactions causing hospital admissions. Br J Clin Pharmacol. 2012;74:1045–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Gill K, Pande R, Malhotra A. Women deliver for development. Lancet. 2007;370:1347–57.

    Article  PubMed  Google Scholar 

  76. Hellden A, Bergman U, von Euler M, Hentschke M, Odar-Cederlof I, Ohlen G. Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study. Drugs Aging. 2009;26:595–606.

    Article  CAS  PubMed  Google Scholar 

  77. Bond CA, Raehl CL. Adverse drug reactions in United States hospitals. Pharmacotherapy. 2006;26:601–8.

    Article  CAS  PubMed  Google Scholar 

  78. Thomas EJ, Lipsitz SR, Studdert DM, Brennan TA. The reliability of medical record review for estimating adverse event rates. Ann Intern Med. 2002;136:812–6.

    Article  PubMed  Google Scholar 

  79. Snyder RA, Abarca J, Meza JL, Rothschild JM, Rizos A, Bates DW. Reliability evaluation of the adapted national coordinating council medication error reporting and prevention (NCC MERP) index. Pharmacoepidemiol Drug Saf. 2007;16:1006–13.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pharmacy, School of Medicine, University of Tasmania, Hobart, TAS, Australia

    Mulugeta Tarekegn Angamo, Leanne Chalmers, Colin M. Curtain & Luke R. E. Bereznicki

Authors
  1. Mulugeta Tarekegn Angamo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leanne Chalmers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Colin M. Curtain
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luke R. E. Bereznicki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mulugeta Tarekegn Angamo.

Ethics declarations

Funding

No sources of funding were used to assist in the preparation of this study.

Conflicts of interest

Mulugeta Tarekegn Angamo, Leanne Chalmers, Colin Curtain and Luke Bereznicki have no conflicts of interest that are directly relevant to the content of this study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 176 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Angamo, M.T., Chalmers, L., Curtain, C.M. et al. Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors. Drug Saf 39, 847–857 (2016). https://doi.org/10.1007/s40264-016-0444-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40264-016-0444-7

Keywords

Search

Navigation